CUREVAC NV (1CVAC.MI) Fundamental Analysis & Valuation

BIT:1CVAC • NL0015436031

Current stock price

4.386 EUR
-0.22 (-4.82%)
Last:

This 1CVAC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. 1CVAC.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1CVAC was profitable.
  • In the past year 1CVAC has reported a negative cash flow from operations.
  • In the past 5 years 1CVAC reported 4 times negative net income.
  • In multiple years 1CVAC reported negative operating cash flow during the last 5 years.
1CVAC.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVAC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.31%, 1CVAC belongs to the top of the industry, outperforming 83.13% of the companies in the same industry.
  • 1CVAC has a Return On Equity of 14.79%. This is amongst the best in the industry. 1CVAC outperforms 81.93% of its industry peers.
  • The Return On Invested Capital of 1CVAC (14.12%) is better than 87.95% of its industry peers.
Industry RankSector Rank
ROA 11.31%
ROE 14.79%
ROIC 14.12%
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
1CVAC.MI Yearly ROA, ROE, ROIC1CVAC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • 1CVAC has a better Profit Margin (182.11%) than 96.39% of its industry peers.
  • With an excellent Operating Margin value of 212.01%, 1CVAC belongs to the best of the industry, outperforming 97.59% of the companies in the same industry.
  • 1CVAC has a Gross Margin of 93.01%. This is amongst the best in the industry. 1CVAC outperforms 87.95% of its industry peers.
Industry RankSector Rank
OM 212.01%
PM (TTM) 182.11%
GM 93.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1CVAC.MI Yearly Profit, Operating, Gross Margins1CVAC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1CVAC.MI Health Analysis

2.1 Basic Checks

  • 1CVAC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, 1CVAC has about the same amount of shares outstanding.
  • Compared to 5 years ago, 1CVAC has more shares outstanding
  • The debt/assets ratio for 1CVAC has been reduced compared to a year ago.
1CVAC.MI Yearly Shares Outstanding1CVAC.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
1CVAC.MI Yearly Total Debt VS Total Assets1CVAC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.42 indicates that 1CVAC is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.42, 1CVAC is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that 1CVAC is not too dependend on debt financing.
  • 1CVAC has a Debt to Equity ratio of 0.03. This is in the better half of the industry: 1CVAC outperforms 69.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACC1.97
WACC7.16%
1CVAC.MI Yearly LT Debt VS Equity VS FCF1CVAC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • A Current Ratio of 3.70 indicates that 1CVAC has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 3.70, 1CVAC is doing good in the industry, outperforming 68.67% of the companies in the same industry.
  • 1CVAC has a Quick Ratio of 3.69. This indicates that 1CVAC is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 3.69, 1CVAC is doing good in the industry, outperforming 73.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.69
1CVAC.MI Yearly Current Assets VS Current Liabilites1CVAC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1CVAC.MI Growth Analysis

3.1 Past

  • 1CVAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.83%, which is quite impressive.
  • Looking at the last year, 1CVAC shows a very negative growth in Revenue. The Revenue has decreased by -86.98% in the last year.
  • The Revenue has been growing by 98.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.33%
Revenue 1Y (TTM)-86.98%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-89.41%

3.2 Future

  • Based on estimates for the next years, 1CVAC will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.50% on average per year.
  • Based on estimates for the next years, 1CVAC will show a very negative growth in Revenue. The Revenue will decrease by -10.88% on average per year.
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-10.88%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVAC.MI Yearly Revenue VS Estimates1CVAC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
1CVAC.MI Yearly EPS VS Estimates1CVAC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1CVAC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.56, which indicates a rather cheap valuation of 1CVAC.
  • Based on the Price/Earnings ratio, 1CVAC is valued cheaper than 93.98% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.78, 1CVAC is valued rather cheaply.
  • 1CVAC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 7.56
Fwd PE N/A
1CVAC.MI Price Earnings VS Forward Price Earnings1CVAC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • 1CVAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1CVAC is cheaper than 91.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.58
1CVAC.MI Per share data1CVAC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as 1CVAC's earnings are expected to decrease with -28.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1CVAC.MI Dividend Analysis

5.1 Amount

  • No dividends for 1CVAC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1CVAC.MI Fundamentals: All Metrics, Ratios and Statistics

CUREVAC NV

BIT:1CVAC (12/11/2025, 7:00:00 PM)

4.386

-0.22 (-4.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-24
Earnings (Next)04-08
Inst Owners10.45%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap987.60M
Revenue(TTM)70.74M
Net Income(TTM)128.82M
Analysts73.33
Price Target4.03 (-8.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)557.4%
Min EPS beat(2)-39.67%
Max EPS beat(2)1154.47%
EPS beat(4)2
Avg EPS beat(4)282.88%
Min EPS beat(4)-39.67%
Max EPS beat(4)1154.47%
EPS beat(8)3
Avg EPS beat(8)141.82%
EPS beat(12)5
Avg EPS beat(12)87.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)149.77%
Min Revenue beat(2)-96.47%
Max Revenue beat(2)396.01%
Revenue beat(4)2
Avg Revenue beat(4)82.72%
Min Revenue beat(4)-96.47%
Max Revenue beat(4)396.01%
Revenue beat(8)5
Avg Revenue beat(8)105.08%
Revenue beat(12)5
Avg Revenue beat(12)59.37%
Revenue beat(16)8
Avg Revenue beat(16)72.27%
PT rev (1m)-3.19%
PT rev (3m)-4.52%
EPS NQ rev (1m)966.6%
EPS NQ rev (3m)404.74%
EPS NY rev (1m)-7.12%
EPS NY rev (3m)-7.12%
Revenue NQ rev (1m)33.33%
Revenue NQ rev (3m)34.82%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)-13.75%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE N/A
P/S 13.96
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.17
EV/EBITDA 3.58
EPS(TTM)0.58
EY13.22%
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.31
BVpS3.87
TBVpS3.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.11
Profitability
Industry RankSector Rank
ROA 11.31%
ROE 14.79%
ROCE 16.62%
ROIC 14.12%
ROICexc 26.37%
ROICexgc 27.79%
OM 212.01%
PM (TTM) 182.11%
GM 93.01%
FCFM N/A
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.18
Cap/Depr 28.09%
Cap/Sales 7.01%
Interest Coverage 66.45
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.69
Altman-Z 4.42
F-Score3
WACC7.16%
ROIC/WACC1.97
Cap/Depr(3y)242.45%
Cap/Depr(5y)397%
Cap/Sales(3y)81.47%
Cap/Sales(5y)93.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.33%
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue 1Y (TTM)-86.98%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-89.41%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-10.88%
EBIT growth 1Y13.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-158.29%
EBIT Next 3Y-29.43%
EBIT Next 5YN/A
FCF growth 1Y62.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.06%
OCF growth 3YN/A
OCF growth 5YN/A

CUREVAC NV / 1CVAC.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CUREVAC NV (1CVAC.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1CVAC.MI.


Can you provide the valuation status for CUREVAC NV?

ChartMill assigns a valuation rating of 5 / 10 to CUREVAC NV (1CVAC.MI). This can be considered as Fairly Valued.


How profitable is CUREVAC NV (1CVAC.MI) stock?

CUREVAC NV (1CVAC.MI) has a profitability rating of 6 / 10.


How financially healthy is CUREVAC NV?

The financial health rating of CUREVAC NV (1CVAC.MI) is 9 / 10.


Can you provide the expected EPS growth for 1CVAC stock?

The Earnings per Share (EPS) of CUREVAC NV (1CVAC.MI) is expected to decline by -170.56% in the next year.